Afrezza Interactions
There are 422 drugs known to interact with Afrezza (insulin inhalation, rapid acting), along with 6 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 16 are major, 385 are moderate, and 21 are minor.
- View all 422 medications that may interact with Afrezza
- View Afrezza alcohol/food interactions (1)
- View Afrezza disease interactions (6)
Most frequently checked interactions
View interaction reports for Afrezza (insulin inhalation, rapid acting) and the medicines listed below.
- amlodipine
- aspirin
- atorvastatin
- Bydureon (exenatide)
- carvedilol
- clonidine
- Crestor (rosuvastatin)
- Cymbalta (duloxetine)
- Farxiga (dapagliflozin)
- gabapentin
- Humalog (insulin lispro)
- Humalog KwikPen (insulin lispro)
- hydrochlorothiazide
- Lantus (insulin glargine)
- Lantus SoloStar (insulin glargine)
- levothyroxine
- Linzess (linaclotide)
- losartan
- melatonin
- meloxicam
- metformin
- Ozempic (semaglutide)
- pantoprazole
- trazodone
- Tresiba (insulin degludec)
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D2 (ergocalciferol)
- Vitamin D3 (cholecalciferol)
- Xarelto (rivaroxaban)
Afrezza alcohol/food interactions
There is 1 alcohol/food interaction with Afrezza (insulin inhalation, rapid acting).
Afrezza disease interactions
There are 6 disease interactions with Afrezza (insulin inhalation, rapid acting) which include:
Report options
More about Afrezza (insulin inhalation, rapid acting)
- Afrezza consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (38)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: insulin
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.